Naglazyme Side Effects
|
|
Patientsville.com is the most complete Drug Side Effects Resource on the Internet. View over 1 million side effect patient episodes and learn about side effect symptoms and remedies. Connect with others who had similar side effects. Help Community by Submitting Your Side Effect.
Recently reported Naglazyme Side Effects
Did You Have Naglazyme Side Effect? |
Naglazyme Side Effects Poll Results |
|
Vote Below:
|
|
Naglazyme Comments and Questions
Join the discussion:
No comments have been provided.
Ask Community about Naglazyme:
What is Your Question? Ask Community:
Daily Health Videos
Naglazyme Side Effects reported on Patientsville.com
None reported at this time.Naglazyme Side Effects reported to FDA
Showing 1-50 of 103 Next >
Naglazyme Side Effects Report #5232181-4Physician from UNITED STATES reported Naglazyme side effect on Jan 10, 2007. Female patient, 52 years of age, weighting 121.3 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: atrial fibrillation
, cardio-respiratory arrest, hypotension, hypoxia, myocardial infarction, pneumonia aspiration, pulmonary embolism , type iv hypersensitivity reaction. Naglazyme dosage: 1 MG/KG; QW; IV. During the same period patient was treated with WARFARIN, LASIX, POTASSIUM ACETATE, RANITIDINE, ATENOLOL, ALLEGRA, NIFEREX, COLACE. Patient was hospitalized. Patient died on 12/19/2006.
Naglazyme Side Effects Report #5383875-1
Naglazyme side effect was reported by a Health Professional from UNITED STATES on Apr 27, 2007. Male patient, 25 years of age, weighting 47.84 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: agitation, blood pressure diastolic increased, heart rate increased, infusion related reaction, malaise, oxygen saturation decreased, pallor, refusal of treatment by relative. Naglazyme dosage: 1 MG/MKG; QW; IV. Patient recovered.
Naglazyme Side Effects Report #5397131-9
Health Professional from UNITED STATES reported Naglazyme side effect on July 06, 2007. Female patient, child 7 years of age, weighting 46.96 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, carpal tunnel syndrome
, disease recurrence, gastrointestinal haemorrhage, hypertension, infusion related reaction, mastoiditis, rash erythematous, trigger finger. Naglazyme dosage: 1 MG/KG; QW; IV. During the same period patient was treated with METHYLPHENIDATE, PREDNISONE, LANSOPRAZOLE, CALCIUM CARBONATE, DIPHENHYDRAMINE, CLONIDINE, HYDROCORTISONE SUCCINATE. Patient was hospitalized. Patient recovered.Naglazyme Side Effects Report #5397300-8
Naglazyme side effect was reported by a Health Professional from COLOMBIA on July 06, 2007. Male patient, child 3 years of age, weighting 24.25 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: alpha haemolytic streptococcal infection, cardiac failure congestive, culture positive, pneumonia
, pulmonary hypertension , staphylococcal infection . Naglazyme dosage: 10 MG, QW; IV. During the same period patient was treated with BETA, BRONCHLODIALTOR, OXYGEN, FUROSEMIDE. Patient was hospitalized. Patient recovered.Naglazyme Side Effects Report #5412401-3
Health Professional from UNITED STATES reported Naglazyme side effect on July 25, 2007. Female patient, child 7 years of age, weighting 46.96 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: abdominal pain
, activated partial thromboplastin time prolonged, aortic valve incompetence, carpal tunnel syndrome , condition aggravated, disease recurrence, gastrointestinal haemorrhage, haematochezia, headache . Naglazyme dosage: 1 MG/KG; QW; IV. During the same period patient was treated with METHYLPHENIDATE, PREDNISONE, LANSOPRAZOLE, CALCIUM CARBONATE, DIPHENHYDRAMINE. Patient was hospitalized. Patient recovered.Naglazyme Side Effects Report #5413007-2
Naglazyme side effect was reported by a Health Professional from COLOMBIA on July 25, 2007. Male patient, child 3 years of age, weighting 24.25 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: alpha haemolytic streptococcal infection, cardiac failure congestive, culture positive, oxygen saturation decreased, pneumonia
, pulmonary hypertension , respiratory distress, sleep study abnormal. Naglazyme dosage: 10 MG; QW; IV. During the same period patient was treated with BETA, BRONCHODILATOR, OXYGEN, FUROSEMIDE. Patient was hospitalized. Patient recovered.Naglazyme Side Effects Report #5443298-3
Health Professional from COLOMBIA reported Naglazyme side effect on Aug 15, 2007. Male patient, child 3 years of age, weighting 24.25 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: acute respiratory failure, alpha haemolytic streptococcal infection, cardiac failure congestive, haemodynamic instability, no therapeutic response, pneumonia
, pulmonary hypertension , sleep apnoea syndrome, staphylococcal infection . Naglazyme dosage: 10 MG; QW; IV. During the same period patient was treated with BRONCHODILATOR, OXYGEN, FUROSEMIDE, BETA. Patient was hospitalized. Patient recovered.Naglazyme Side Effects Report #5445686-8
Naglazyme side effect was reported by a Physician from UNITED STATES on Aug 20, 2007. Male patient, 14 years of age, weighting 48.50 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: infusion related reaction, lip swelling, paraesthesia, pruritus, shock, throat tightness. Naglazyme dosage: 25 MG;QW;IV. During the same period patient was treated with FLUVOXAMINE MALEATE, ACETAZOLAMIDE, SUDAFED, ZANTAC, CLARITIN, BENADRYL. Patient recovered.
Naglazyme Side Effects Report #5464001-7
Consumer or non-health professional from UNITED STATES reported Naglazyme side effect on Sept 05, 2007. Female patient, child 7 years of age, weighting 46.96 lb, was diagnosed with mucopolysaccharidosis vi, attention deficit/hyperactivity disorder and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: abdominal pain
, activated partial thromboplastin time prolonged, anal fissure, aortic valve incompetence, carpal tunnel syndrome , chest pain , disease recurrence, dizziness , dysuria. Naglazyme dosage: 1 MG/KG; QW; IV. During the same period patient was treated with METHYLPHENIDATE, PREDNISONE, LANSOPRAZOLE, CALCIUM CARBONATE, DIPHENHYDRAMINE, CLONIDINE. Patient was hospitalized. Patient recovered.Naglazyme Side Effects Report #5466035-5
Naglazyme side effect was reported by a Physician from BRAZIL on Sept 04, 2007. Female patient, child 8 years of age, weighting 28.66 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: abdominal pain
, apnoea, bradycardia, choking , dyspnoea, pyrexia. Naglazyme dosage: 1 MG/KG; QW; IV. During the same period patient was treated with BENADRYL. Patient recovered.Naglazyme Side Effects Report #5565056-1
Physician from BRAZIL reported Naglazyme side effect on Nov 27, 2007. Female patient, child 8 years of age, weighting 72.75 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: abdominal pain
, apnoea, bradycardia, choking , dyspnoea, hyperthermia, hypothermia . Naglazyme dosage: 1 MG/KG;QW;IV. During the same period patient was treated with BENADRYL. Patient recovered.Naglazyme Side Effects Report #5578195-6
Naglazyme side effect was reported by a Physician from FRANCE on Dec 18, 2007. Female patient, child 10 years of age, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: respiratory failure. Naglazyme dosage: unknown. Patient died on 11/01/2007.
Naglazyme Side Effects Report #5586061-5
Physician from BRAZIL reported Naglazyme side effect on Dec 20, 2007. Male patient, child 7 years of age, weighting 32.19 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: clonus, condition aggravated, disease progression, gait disturbance, hyperreflexia, hypotonia, muscle spasticity, muscular weakness, off label use. Naglazyme dosage: 1.5 ML; QM;INTH; 15 MG; X1; IV. Patient recovered.
Naglazyme Side Effects Report #5591022-6
Naglazyme side effect was reported by a Physician from BRAZIL on Dec 26, 2007. Male patient, child 7 years of age, weighting 32.19 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: arthropathy, csf protein increased, disease progression, meningeal disorder, myelopathy, nuclear magnetic resonance imaging brain abnormal, spinal cord compression. Naglazyme dosage: 1.5 ML; QM; INTH; 15 MG; X1; IV. Patient recovered.
Naglazyme Side Effects Report #5594001-8
Physician from GERMANY reported Naglazyme side effect on Jan 02, 2008. Female patient, 19 years of age, weighting 44.09 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: hypersensitivity, hypertension, rash
, urticaria. Naglazyme dosage: 5 MG;IV. Patient recovered.Naglazyme Side Effects Report #5613391-0
Naglazyme side effect was reported by a Physician from BRAZIL on Jan 11, 2008. Male patient, child 7 years of age, weighting 32.19 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: abasia, central nervous system lesion, clonus, condition aggravated, csf protein increased, hyperreflexia, hypotonia, meningeal disorder, muscle spasticity. Naglazyme dosage: 1.5 ML;QM;INTH, 15 MG;X1;IV. Patient recovered.
Naglazyme Side Effects Report #5614216-X
Physician from FRANCE reported Naglazyme side effect on Jan 15, 2008. Female patient, child 10 years of age, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: bronchial disorder, cardiopulmonary failure, infection
, lung disorder. Naglazyme dosage: unknown. Patient died on 11/01/2007.Naglazyme Side Effects Report #5614706-X
Naglazyme side effect was reported by a Health Professional from IRELAND on Jan 16, 2008. Female patient, 13 years of age, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: pneumonia
, pulmonary hypertension . Naglazyme dosage: unknown. Patient was hospitalized. Patient recovered.Naglazyme Side Effects Report #5614707-1
Physician from PORTUGAL reported Naglazyme side effect on Jan 16, 2008. Male patient, 14 years of age, weighting 94.80 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: blood pressure increased, body temperature increased, cyanosis, dyspnoea, haemorrhage, infusion related reaction, oxygen saturation decreased, pharyngeal oedema, rash
. Naglazyme dosage: QW IV ; 43 MG 1X IV. Patient recovered.Naglazyme Side Effects Report #5614708-3
Naglazyme side effect was reported by a Physician from COLOMBIA on Jan 16, 2008. Male patient, child 11 years of age, weighting 39.68 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: pulmonary hypertension
, tonsillitis. Naglazyme dosage: unknown. Patient was hospitalized. Patient recovered.Naglazyme Side Effects Report #5615549-3
Physician from GERMANY reported Naglazyme side effect on Jan 17, 2008. Female patient, child 9 years of age, weighting 44.09 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: anaphylactic reaction, anaphylactoid reaction, cough, hypersensitivity, hypertension, infusion related reaction. Naglazyme dosage: 5MG; IV, 15 MG; IV. During the same period patient was treated with DIMETINDENE MALEATE, PREDNISOLONE, RANITIDINE. Patient was hospitalized. Patient recovered.
Naglazyme Side Effects Report #5629946-3
Naglazyme side effect was reported by a Physician from BRAZIL on Jan 30, 2008. Male patient, child 7 years of age, weighting 32.19 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: abasia, cervical cord compression, disease progression, hypotonia, meningeal disorder, pyramidal tract syndrome. Naglazyme dosage: 1.5 ML; QM; INTH, 15 MG; X1; IV, 15 MG; X1; IV, 1.5 ML; X1; INTH, 15 MG; X1; IV. Patient recovered.
Naglazyme Side Effects Report #5629947-5
Health Professional from IRELAND reported Naglazyme side effect on Jan 28, 2008. Female patient, 13 years of age, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: cardiac arrest
, pneumonia , pulmonary hypertension . Naglazyme dosage: unknown. Patient was hospitalized. Patient died on 01/01/2008.Naglazyme Side Effects Report #5646419-2
Naglazyme side effect was reported by a Physician from IRELAND on Feb 13, 2008. Female patient, child 11 years of age, weighting 44.09 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: aortic valve incompetence, cardiac arrest
, mitral valve incompetence, pneumonia , pulmonary haemorrhage, pulmonary hypertension , respiratory tract infection, tricuspid valve incompetence. Naglazyme dosage: 20 MG QW IV. During the same period patient was treated with MEROPENEM, VANCOMYCIN, ERYTHROMYCIN, CIPROFLOXACIN, VORICONAZOLE, MILRINONE LACTATE, FUROSEMIDE, MORPHINE. Patient was hospitalized. Patient died on 01/25/2008.Naglazyme Side Effects Report #5663681-0
Physician from BRAZIL reported Naglazyme side effect on Feb 22, 2008. Male patient, child 7 years of age, weighting 32.19 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: condition aggravated, diffuse axonal injury, gait disturbance, hypotonia, intervertebral disc disorder, muscle spasticity, oxygen saturation decreased, pyramidal tract syndrome. Naglazyme dosage: 1.5 ML;QM;INTH;15 MG;X1;IV. Patient recovered.
Naglazyme Side Effects Report #5673975-0
Naglazyme side effect was reported by a Consumer or non-health professional from IRELAND on Feb 29, 2008. Female patient, child 11 years of age, weighting 44.09 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: abdominal pain upper, aortic valve incompetence, back pain
, blood pressure decreased, cardiac arrest , diarrhoea, headache , hepatomegaly. Naglazyme dosage: 20 MG; QW; IV. During the same period patient was treated with MEROPENEM, VANCOMYCIN, ERYTHROMYCIN, CIPROFLOXACIN, VORICONAZOLE, MILRINONE LACTATE, FUROSEMIDE, MORPHINE. Patient was hospitalized. Patient died on 01/25/2008.Naglazyme Side Effects Report #5679318-0
Physician from UNITED ARAB EMIRATES reported Naglazyme side effect on Mar 06, 2008. Female patient, child 4 years of age, weighting 24.25 lb, was diagnosed with mucopolysaccharidosis iv and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: respiratory tract infection. Naglazyme dosage: 10 MG,QW;IV. Patient died on 02/28/2008.
Naglazyme Side Effects Report #5679361-1
Naglazyme side effect was reported by a Consumer or non-health professional from BRAZIL on Mar 05, 2008. Male patient, child 11 years of age, weighting 55.12 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: chest x-ray abnormal, dyspnoea at rest, oedema peripheral, pneumonia
. Naglazyme dosage: 25 MG; QW; IV. During the same period patient was treated with FUROSEMIDE, CAPTOPRIL, CLAVULANATE POTASSIUM. Patient was hospitalized. Patient recovered.Naglazyme Side Effects Report #5682171-2
Physician from PORTUGAL reported Naglazyme side effect on Mar 10, 2008. Male patient, 14 years of age, weighting 94.80 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: blood pressure increased, body temperature increased, cyanosis, dyspnoea, oxygen saturation decreased, rash
, tachycardia, tremor. Naglazyme dosage: QW;IV; 43 MG;QW;IV. During the same period patient was treated with CLEMASTINE FUMARATE. Patient recovered.Naglazyme Side Effects Report #5694143-2
Naglazyme side effect was reported by a Health Professional from UNITED STATES on Mar 18, 2008. Female patient, child 7 years of age, weighting 46.96 lb, was diagnosed with mucopolysaccharidosis vi, attention deficit/hyperactivity disorder and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, carpal tunnel syndrome
, disease recurrence, gastrointestinal haemorrhage, malignant hypertension, urticaria. Naglazyme dosage: 1MG/KG; QW; IV. During the same period patient was treated with METHYLPHENIDATE, PREDNISONE, LANSOPRAZOLE, CALCIUM CARBONATE, DIPHENHYDRAMINE, HYDROCORTISONE SUCCINATE. Patient was hospitalized. Patient recovered.Naglazyme Side Effects Report #5704286-2
Physician from BRAZIL reported Naglazyme side effect on Mar 25, 2008. Male patient, child 7 years of age, weighting 32.19 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: abasia, clonus, disease progression, hyperreflexia, hypotonia, ill-defined disorder, immune system disorder, muscle spasticity, muscular weakness. Naglazyme dosage: 1.5 ML; QM; INTH, 15 MG; X1; IV, 15 MG; X1; IV, 1.5 ML; X1; INTH, 15 MG; X1; IV, 1 ML/KG; QW; IV. Patient recovered.
Naglazyme Side Effects Report #5705953-7
Naglazyme side effect was reported by a Physician from COLOMBIA on Mar 27, 2008. Male patient, 14 years of age, weighting 41.89 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: spinal cord compression. Naglazyme dosage: 20 MG QW IV. Patient was hospitalized. Patient recovered.
Naglazyme Side Effects Report #5710515-1
Physician from UNITED STATES reported Naglazyme side effect on Mar 31, 2008. Male patient, 15 years of age, weighting 48.50 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: blood culture positive, haematuria, infection
, sepsis . Naglazyme dosage: 1 MG/KG; QW; IV. During the same period patient was treated with DIAMOX SRC, ZANTAC, LORATADINE. Patient was hospitalized. Patient recovered.Naglazyme Side Effects Report #5723213-5
Naglazyme side effect was reported by a Physician from UNITED STATES on Apr 10, 2008. Male patient, 15 years of age, weighting 48.50 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: anaemia, haematuria, infusion site erythema, infusion site pain, infusion site swelling, injury, nephrolithiasis, sepsis
, staphylococcal infection . Naglazyme dosage: 1 MG/KG; QW; IV. During the same period patient was treated with DIAMOX SRC, ZANTAC, LORATADINE, MONTELUKAST, FLUVOXAMINE MALEATE. Patient was hospitalized. Patient recovered.Naglazyme Side Effects Report #5724438-5
Physician from BRAZIL reported Naglazyme side effect on Apr 11, 2008. Male patient was diagnosed with mucopolysaccharidosis and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: infection
, sepsis . Naglazyme dosage: unknown. Patient died on 04/06/2008.Naglazyme Side Effects Report #5724467-1
Naglazyme side effect was reported by a Consumer or non-health professional from AUSTRALIA on Apr 14, 2008. Female patient, 14 years of age, weighting 35.27 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: blood pressure decreased, chills, dizziness
, dyspnoea, emotional distress, infusion related reaction, irritability, livedo reticularis. Naglazyme dosage: 20 MG;QW;IV. During the same period patient was treated with MONTELUKAST, FLUTICASONE, ALBUTEROL, BUDESONIDE, ROXITHROMYCIN, AUGMENTIN, PREDNISOLONE, CIPROFLOXACIN. Patient was hospitalized. Patient recovered.Naglazyme Side Effects Report #5729880-4
Physician from UNITED STATES reported Naglazyme side effect on Apr 17, 2008. Male patient, 15 years of age, weighting 48.50 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: anaemia, bacteria urine identified, blood potassium decreased, calculus ureteric, catheter site erythema, constipation
, ear infection , hydronephrosis, infusion site reaction. Naglazyme dosage: 1 MG/KG; QW; IV. During the same period patient was treated with DIAMOX, ZANTAC, LORATADINE, MONTELUKAST, FLUVOXAMINE MALEATE, CEFAZOLIN, MIRALAX, MOTRIN. Patient was hospitalized. Patient recovered.Naglazyme Side Effects Report #5739542-5
Naglazyme side effect was reported by a Physician from BRAZIL on Apr 28, 2008. Male patient, child 9 years of age, weighting 35.27 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: sepsis
. Naglazyme dosage: 15 MG, 1X, IV. During the same period patient was treated with TAZOCIN. Patient died on 04/06/2008.Naglazyme Side Effects Report #5748892-8
Physician from COLOMBIA reported Naglazyme side effect on May 07, 2008. Male patient, 14 years of age, weighting 41.89 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: spinal cord compression, treatment noncompliance. Naglazyme dosage: 20 MG; QW; IV. During the same period patient was treated with ALBUTEROL. Patient was hospitalized. Patient recovered.
Naglazyme Side Effects Report #5776618-0
Naglazyme side effect was reported by a Physician from COLOMBIA on June 02, 2008. Male patient, child 12 years of age, weighting 39.68 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: bronchial obstruction, cardiac failure, cardio-respiratory arrest, cardiomyopathy
, disease progression, mucopolysaccharidosis vi, multi-organ failure, pulmonary hypertension , renal failure. Naglazyme dosage: 20 MG; QW; IV. During the same period patient was treated with ALDACTONE, FUROSEMIDE, SILDENAFIL, CARVEDILOL. Patient was hospitalized. Patient died on 04/22/2008.Naglazyme Side Effects Report #5796870-5
Physician from BRAZIL reported Naglazyme side effect on Mar 26, 2008. Male patient, child 7 years of age, weighting 32.19 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: condition aggravated, disease progression, gait disturbance, hypotonia, muscle spasticity, muscular weakness, nuclear magnetic resonance imaging brain abnormal, oxygen saturation decreased. Naglazyme dosage: 1.5 ML QM INTH; 15 MG X1 IV; 15 MG X1 IV; 1.5 ML X1 INTH; 15 MG X1 IV; 1 ML/KG QW IV. Patient recovered.
Naglazyme Side Effects Report #5803884-5
Naglazyme side effect was reported by a Physician from FRANCE on June 18, 2008. Male patient, child 5 years of age, weighting 29.76 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: nephritic syndrome, nephrotic syndrome. Naglazyme dosage: unknown. Patient was hospitalized. Patient recovered.
Naglazyme Side Effects Report #5827002-2
Physician from FRANCE reported Naglazyme side effect on July 10, 2008. Male patient, child 5 years of age, weighting 29.76 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: nephritic syndrome, nephrotic syndrome. Naglazyme dosage: unknown. Patient was hospitalized. Patient recovered.
Naglazyme Side Effects Report #5828150-3
Naglazyme side effect was reported by a Physician from BRAZIL on July 14, 2008. Male patient, child 9 years of age, weighting 39.68 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: cardiac arrest
, poor venous access, pyrexia. Naglazyme dosage: 1 MG/KG; QW; IV. Patient died on 06/27/2008.Naglazyme Side Effects Report #5858094-2
Physician from FRANCE reported Naglazyme side effect on Aug 07, 2008. Male patient, child 5 years of age, weighting 29.76 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: nephritic syndrome, nephrotic syndrome. Naglazyme dosage: MG; QW; IVDRIP; IVDRIP. During the same period patient was treated with DOLIPRANE. Patient was hospitalized. Patient recovered.
Naglazyme Side Effects Report #5861735-7
Naglazyme side effect was reported by a Physician from BRAZIL on Aug 11, 2008. Male patient, child 9 years of age, weighting 35.27 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: klebsiella sepsis, pseudomonal sepsis. Naglazyme dosage: 15 MG; 1X; IV. During the same period patient was treated with TAZOCIN, MIDAZOLAM, DOPAMINE, DEXAMETHASONE, DOBUTAMINE, DIGOXIN, PHENOBARBITAL, ACETAMINOPHEN. Patient was hospitalized. Patient died on 04/04/2008.
Naglazyme Side Effects Report #5871208-3
Physician from COLOMBIA reported Naglazyme side effect on Aug 12, 2008. Male patient, child 5 years of age, weighting 24.25 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: adenoidectomy, myringotomy, tonsillectomy. Naglazyme dosage: 10 MG;QW;IVDRP. During the same period patient was treated with CETIRIZIN, CEFALEXIN, OXYGEN. Patient was hospitalized. Patient recovered.
Naglazyme Side Effects Report #5873085-3
Naglazyme side effect was reported by a Physician from FRANCE on Aug 18, 2008. Male patient, child 5 years of age, weighting 29.76 lb, was diagnosed with mucopolysaccharidosis iv and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: nephritic syndrome, nephropathy, nephrotic syndrome. Naglazyme dosage: 15 MG;QW;IVDRP;QW;IVDRP. During the same period patient was treated with DOIPRANE, PARACETAMOL, HYDROXYZINE, WARFARIN. Patient was hospitalized. Patient recovered.
Naglazyme Side Effects Report #5873086-5
Physician from AUSTRALIA reported Naglazyme side effect on Aug 16, 2008. Female patient, weighting 22.05 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: anaphylactic reaction, shock, vomiting. Naglazyme dosage: 10.5 MG;QW;IVDRP; QW;IVDRP. During the same period patient was treated with CETIRIZINE, IBUPROFEN. Patient was hospitalized. Patient recovered.
Naglazyme Side Effects Report #5893094-8
Naglazyme side effect was reported by a Consumer or non-health professional from AUSTRALIA on Sept 04, 2008. Female patient, 28 years of age, weighting 68.34 lb, was diagnosed with mucopolysaccharidosis vi and was treated with Naglazyme. After drug was administered, patient experienced the following side effects: pneumonia
, sepsis . Naglazyme dosage: 22 MG; QW; IVDRP. Patient was hospitalized. Patient died on 09/02/2008.Showing 1-50 of 103 Next >
Advise and Guidance
Carpal tunnel syndrome and Are your wrists at risk?
Infection and Kids' vaccinations
Infection and Urinary tract infections
Infection and What is a sexually transmitted disease (std)?